Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	20.98	53.68	44.37
Graham Fair Price	-15.18	28.40	33.49
PEG	-0.58	-1.12	-1.11
Price/Book	0.06	3.14	3.14
Price/Cash Flow	-148.56	-66.53	-26.77
Prices/Earnings	41.59	32.39	22.88
Price/Sales	19.21	15.76	13.22
Price/FCF	-148.56	-66.53	-26.77
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.25	0.47	0.50
Operating Margin	-9.30	0.23	0.25
ROA	-30.09	0.01	0.01
ROE	0.03	0.02	-29.33
ROIC	0.02	0.02	-15.22
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	0.14	-67.34
Dividends QOQ	< 0.005	0.03	115602.02
EBIT QOQ	-0.16	-0.23	-41.07
EPS QOQ	-0.21	-0.29	-40.77
FCF QOQ	-108.35	0.59	-99.45
Revenue QOQ	-0.09	-0.15	-69.27
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	22.23	100.00
Days Sales Outstanding (DSO)	92.35	101.56	9.97
Inventory Turnover	0.00	4.05	100.00
Debt/Capitalization	0.45	0.42	-8.13
Quick Ratio	0.82	1.40	70.96
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	38.13	38.47	0.90
Cash	0.04	0.08	117.83
Capex	-3.51	-4.24	-20.87
Free Cash Flow	-4.47	-1.82	59.38
Revenue	9.05	7.66	-15.31
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.82	1.40	70.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.16	11.38	24.27
Naive Interpretation	Member

06 - Financial Health · Weak

Rating